Lindenwold Advisors’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,270
Closed -$277K 114
2024
Q3
$277K Buy
4,270
+75
+2% +$4.82K 0.14% 103
2024
Q2
$260K Sell
4,195
-48
-1% -$3.33K 0.14% 97
2024
Q1
$359K Buy
+4,243
New +$337K 0.19% 86
2023
Q4
Sell
-4,236
Closed -$293K 115
2023
Q3
$293K Buy
4,236
+21
+0.5% +$1.5K 0.18% 89
2023
Q2
$306K Sell
4,215
-1,341
-24% -$90.6K 0.19% 87
2023
Q1
$400K Sell
5,556
-11
-0.2% -$842 0.25% 79
2022
Q4
$415K Sell
5,567
-378
-6% -$27.1K 0.28% 77
2022
Q3
$390K Buy
5,945
+113
+2% +$8.65K 0.29% 77
2022
Q2
$411K Buy
5,832
+67
+1% +$5.4K 0.29% 76
2022
Q1
$530K Buy
5,765
+285
+5% +$26.8K 0.33% 71
2021
Q4
$555K Buy
+5,480
New +$559K 0.32% 73

Other funds holding CRI

Lindenwold Advisors's CRI Position: Q4 2024 in Review

Lindenwold Advisors sold out of Carter's (CRI) in Q4 2024, closing a stake of 4,270 shares — an estimated $277K sold.

Lindenwold Advisors first reported a position in CRI in Q4 2021 and held it in 11 quarters. The position peaked at $555K in Q4 2021. 317 funds tracked by Wall St. Rank hold CRI as of Q4 2024.

  • Lindenwold Advisors reported no remaining Carter's position as of Q4 2024 after selling out during the quarter.
  • Lindenwold Advisors sold 4,270 Carter's shares in Q4 2024, an estimated $277K.
  • Lindenwold Advisors first reported a position in Carter's in Q4 2021 and held it in 11 quarters.
  • Lindenwold Advisors's Carter's position peaked at $555K in Q4 2021.
  • 317 funds tracked by Wall St. Rank held Carter's as of Q4 2024.

Based on Lindenwold Advisors's 13F filing for Q4 2024, filed 11 Feb 2025.